Organon (OGN) Receivables (2020 - 2026)

Organon (OGN) has reported Receivables for 7 consecutive years, with $1.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables fell 5.01% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (down 5.01% YoY), while the FY2025 annual figure was $1.3 billion, down 1.99% from the prior year.
• Receivables came in at $1.4 billion for Q1 2026 at Organon, up from $1.3 billion in the prior quarter.
• The five-year high for Receivables was $1.9 billion in Q2 2022, with the low at $1.3 billion in Q4 2025.
• Average Receivables over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2023.
• The largest YoY upside for Receivables was 66.34% in 2022 against a maximum downside of 23.22% in 2022.
• Year by year, Receivables stood at $1.8 billion in 2022, then decreased by 5.68% to $1.7 billion in 2023, then dropped by 22.13% to $1.4 billion in 2024, then dropped by 1.99% to $1.3 billion in 2025, then climbed by 3.98% to $1.4 billion in 2026.
• According to Business Quant data, Receivables over the past three periods registered $1.4 billion, $1.3 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.